KAKKIS EMIL D
SEC CIK 1248093 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | Pres, CEO, Dir | 735.7K | — | $13.71M | 23 | 2021-10-14 | 2026-04-16 |
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-20 17:19 | 2026-04-16 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +76.7K | 735.7K | +12% | $0 |
| 2026-03-03 | 2026-03-02 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $22.80 | -54.4K | 659.0K | -8% | -$1.24M | |
| 2026-03-03 | 2026-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +71.2K | 712.9K | +11% | $0 | |
| DTI | 2025-03-04 | 2025-02-28 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $42.48 | -25.0K | 2.16M | -1% | -$1.06M |
| DMT | 2025-03-04 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +150.6K | 607.9K | +33% | $0 |
| DT | 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $42.10 | -73.4K | 641.7K | -10% | -$3.09M |
| TI | 2024-12-31 | 2024-12-30 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $42.23 | -11.7K | 2.18M | -0.5% | -$495.2K |
| TI | 2024-12-11 | 2024-12-09 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | G - Gift | $0.00 | -20.0K | 2.20M | -0.9% | $0 |
| TI | 2024-12-11 | 2024-12-10 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $50.00 | -8,273 | 2.20M | -0.4% | -$413.6K |
| TI | 2024-09-05 | 2024-09-03 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $55.85 | -20.0K | 2.22M | -0.9% | -$1.12M |
| TI | 2024-08-07 | 2024-08-06 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $50.17 | -20.0K | 2.24M | -0.9% | -$1.00M |
| DM | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +41.6K | 563.9K | +8% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $53.69 | -17.4K | 560.8K | -3% | -$935.1K |
| 2024-02-08 | 2024-02-07 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $45.00 | -30.0K | 539.8K | -5% | -$1.35M | |
| 2024-01-02 | 2023-12-29 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $47.87 | -30.0K | 569.8K | -5% | -$1.44M | |
| D | 2023-10-23 | 2023-10-19 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | M - OptEx | $6.86 | +47.9K | 647.0K | +8% | +$328.3K |
| D | 2023-10-23 | 2023-10-19 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale+OE | $33.52 | -47.9K | 599.7K | -7% | -$1.60M |
| DM | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +54.9K | 569.4K | +11% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $45.65 | -16.1K | 599.2K | -3% | -$736.8K |
| 2023-01-03 | 2022-12-30 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $45.57 | -19.6K | 541.1K | -3% | -$892.4K | |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $67.37 | -12.2K | 582.2K | -2% | -$819.4K |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +52.0K | 634.2K | +9% | $0 |
| 2021-10-18 | 2021-10-14 | RARE | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $81.00 | -853 | 594.3K | -0.1% | -$69.1K |
Purchase Sale Sale after option exercise All abbreviations